Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-15T02:23:06.584Z Has data issue: false hasContentIssue false
  • English
  • Français

The response to sulpiride in major depression before and after cognitive behavioural therapy: D2 receptor function

Published online by Cambridge University Press:  24 June 2014

CJ Bell,
S Bhikka,
R Porter,
C Frampton,
J Carter and
PR Joyce
CJ Bell
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
S Bhikka
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
R Porter
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
C Frampton
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
J Carter
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
PR Joyce
Affiliation:
Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Information
Acta Neuropsychiatrica , Volume 18 , Issue 6 , December 2006, pp. 278
Copyright
Copyright © 2006 Blackwell Munksgaard

Background:

Previous studies of D2 receptor function in depressed patients have shown mixed results, with some (but not all) reporting increased sensitivity/ upregulation of D2 receptors in untreated depression, while others report that effective treatment results in increased sensitivity/upregulation.

Methods:

D2 receptor function was assessed in 24 patients with major depression before and 16 patients after 16 weeks of treatment with cognitive behavioural therapy (CBT) using a challenge with a selective D2 antagonist, sulpiride. Four hundred milligrams of sulpiride was administered orally on two test days and response measured in two different dopaminergic pathways: the change in prolactin secretion (tuberoin-fundibular pathway) and changes in self-rating scale measures of mood (VAS, POMS), anxiety (STAI) and pleasure (SHPS) (mesocorticolimbic pathway).

Results:

There was no significant difference in the prolactin response to sulpiride before and after treatment (z = −1.4, P = 0.156). On both test days, sulpiride led to an improvement in mood (VAS and POMS scales). After CBT, this effect was significantly reduced as measured by the POMS scale (t = −2.3, P = 0.038) but unchanged on the VAS scale. Although patients exhibited significant clinical improvement after treatment (as measured by percentage improvement in HDRS score), there was no correlation between response to CBT and changes in response to sulpiride in either pathway.

Conclusions:

No change in tuberoinfundibular D2 receptor function was detected following CBT. A change in mesocorticolimbic D2 receptor function was detected; however, no relationship between changes in D2 receptor sensitivity and clinical response to CBT was evident in this group of depressed patients.